HomeQuestion
What are your top takeaways from AHA 2024?
1 Answers
Mednet Member
Cardiology · University of Nebraska Medical Center
My top three takeaways from the American Heart Association (AHA) 2024 Scientific Sessions:
- SUMMIT Trial: Tirzepatide in Heart Failure with Preserved Ejection Fraction (HFpEF)
- The SUMMIT trial evaluated the efficacy of tirzepatide, a GLP-1 receptor agonist, in patients with obesity and HFpEF. The st...